amcenestrant (SAR439859)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for amcenestrant (SAR439859), covering 2022-06-29 to 2025-07-07. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2) [Phase 1]